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Abstract
Objective: The Maternal Mental Health in Canada, 2018/2019, survey reported that 18% of 7,085 mothers who recently gave
birth reported “feelings consistent with postpartum depression” based on scores 7 on a 5-item version of the Edinburgh
Postpartum Depression Scale (EPDS-5). The EPDS-5 was designed as a screening questionnaire, not to classify disorders or
estimate prevalence; the extent to which EPDS-5 results reflect depression prevalence is unknown. We investigated EPDS-5
7 performance relative to major depression prevalence based on a validated diagnostic interview, the Structured Clinical
Interview for DSM (SCID).
Methods: We searched Medline, Medline In-Process & Other Non-Indexed Citations, PsycINFO, and the Web of Science
Core Collection through June 2016 for studies with data sets with item response data to calculate EPDS-5 scores and that
used the SCID to ascertain depression status. We conducted an individual participant data meta-analysis to estimate pooled
percentage of EPDS-5 7, pooled SCID major depression prevalence, and the pooled difference in prevalence.
Results: A total of 3,958 participants from 19 primary studies were included. Pooled prevalence of SCID major depression
was 9.2% (95% confidence interval [CI] 6.0% to 13.7%), pooled percentage of participants with EPDS-57 was 16.2% (95% CI
10.7% to 23.8%), and pooled difference was 8.0% (95% CI 2.9% to 13.2%). In the 19 included studies, mean and median ratios of
EPDS-5 to SCID prevalence were 2.1 and 1.4 times.
Conclusions: Prevalence estimated based on EPDS-5 7 appears to be substantially higher than the prevalence of major
depression. Validated diagnostic interviews should be used to establish prevalence.
Abrégé
Objectif : L’enquête de 2018-2019 sur la santé mentale maternelle au Canada a révélé que 18 % des 7 085 mères qui ont donné
naissance récemment ont déclaré des « sentiments compatibles avec la dépression du postpartum » d’après des scores 7 à la
version en 5 items de l’échelle de dépression postpartum d’Édimbourg (EDPE-5). L’échelle EDPE-5 a été conçue comme un
questionnaire de dépistage, et non pas pour classer les troubles ou estimer la prévalence; la mesure dans laquelle les résultats de
l’EDPE reflètent la prévalence de la dépression est inconnue. Nous avons investigué le rendement de l’EDPE-57 relativement à la
prévalence de la dépression majeure d’après une entrevue diagnostique validée, l’entrevue clinique structurée pour le DSM (ECSD).
Méthodes : Nous avons cherché dans Medline, Medline In-Process & Other Non-Indexed Citations, PsycINFO, et Web of
Science Core Collection jusqu’en juin 2016 des études qui comportaient des ensembles de données et des données de
réponse aux items afin de calculer les scores à l’EDPE-5, et qui utilisaient l’ECSD pour estimer l’état de la dépression. Nous
avons mené une méta-analyse des données individuelles des participants pour estimer le pourcentage regroupé de l’EDPE-5
7, l’ECSD regroupée pour la prévalence de la dépression majeure, et la différence de prévalence regroupée.
Résultats : Tirés de 19 études principales, 3 958 participants ont été inclus. La prévalence regroupée de la dépression majeure
selon l’ECSD était de 9,2 % (intervalle de confiance [IC] à 95 % 6,0 % à 13,7 %), le pourcentage regroupé des participants ayant
une EDPE-57 était de 16,2 % (IC à 95 % 10,7 % à 23,8 %), et la différence regroupée était de 8,0 % (IC à 95 % 2,9 % à 13,2 %).
Dans les 19 études incluses, le rapport moyen et médian de l’EDPE-5 à la prévalence ECSD était de 2,1 et de 1,4 fois.
Conclusions : La prévalence estimée selon l’EDPE-5 7 semble substantiellement plus élevée que la prévalence de la
dépression majeure. Des entrevues diagnostiques validées devraient être employées pour établir la prévalence.
Keywords
epidemiology, evidence-based medicine, obstetrics and gynecology, psychiatry, statistics and research methods
Depression during pregnancy and the postpartum period is asso-
ciated with negative implications for maternal health, child
health, and families.1-3 Accurate estimation of depression pre-
valence in this population is important for understanding disease
burden, making informed decisions regarding health care
resources, and investigating etiology and challenges associated
with the condition. Systematic reviews have reported postpar-
tum depression prevalence as approximately 7% based on Diag-
nostic and Statistical Manual (DSM) criteria.4,5 A study of over
14,000 women in the United States found that 8% of women in
pregnancy and 9% of women within 12 months postpartum met
DSM-IV criteria for depression based on a diagnostic interview,
compared to 8% among same-aged women.6
The Maternal Mental Health in Canada, 2018/2019, survey
reported that 18% of 7,085 mothers who gave birth between 5
and 13 months prior reported “feelings consistent with post-
partum depression”7 based on scoring7on a 5-item version of
the Edinburgh Postpartum Depression Scale (EPDS-5).8 Self-
report questionnaires, including the EPDS-5, include some
symptoms used to diagnose depression, but they do not include
all relevant symptoms, consideration of functional impairment,
or information needed for differential diagnosis.9-11
Cutoff thresholds on screening tools are typically set to cast
a wide net and identify people who may benefit from further
evaluation but not to determine whether diagnostic criteria are
met or estimate prevalence.9-11 Ascertainment of case status
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and prevalence estimation require the use of a validated diag-
nostic interview, such as the Structured Clinical Interview for
DSM (SCID).12 The 10-item EPDS is commonly researched.
Less is known about the performance of the EPDS-5, which
has been evaluated only in a single study of 56 women (9
depression cases). Knowledge about how it performs in a
larger sample would greatly assist interpretation of Maternal
Mental Health in Canada results and inform recommendations
about its use for describing disease burden.
This study used data from an individual participant data
meta-analysis (IPDMA) on EPDS depression screening tool
accuracy to compare the proportion of women in pregnancy
or postpartum with scores 7 on the EPDS-5 to prevalence
of major depression based on the SCID.
Methods
This study was conducted with data accrued for an IPDMA
on EPDS screening accuracy. The original IPDMA was reg-
istered (PROSPERO; CRD42015024785), and a protocol
was published.13 This study was not included in the main
EPDS IPDMA protocol. It was conducted using methods
from a similar study of prevalence based on the full EPDS
with the protocol uploaded to the Open Science Framework
prior to initiating analyses (https://osf.io/7gy6p/).
Identification of Eligible Studies
Data sets from articles in any language were eligible for the
main IPDMA if (1) they included EPDS scores for women
during pregnancy or within 12 months postpartum; (2) they
included current Major Depressive Episode or Major Depres-
sive Disorder (MDD) classifications based on DSM14-16 or
International Classification of Diseases17 criteria based on a
validated semi-structured or fully structured interview; (3) the
EPDS and interview were done within 2 weeks of each other;
(4) participants were 18 years old and not recruited from
school settings, since the database was originally accrued to
assess screening accuracy among adults, and school-based
screening may have different characteristics; and (5) partici-
pants were not recruited from psychiatric settings or because
they were preidentified as possibly having depression. Data
sets where not all participants were eligible were included if
individual eligible participants could be identified.
In this study, we included only data from primary studies
that based major depression diagnoses on the SCID.12 It is
intended for administration by a trained diagnostician,
requires clinical judgment, and allows probes to be made
to clarify responses. We only included studies that used the
SCID because semi-structured interviews replicate diagnos-
tic standards more closely than other types of interviews, and
the SCID is by far the most commonly used semi-structured
diagnostic interview for depression research.18-20 Three pre-
vious analyses that used large IPDMA databases found that,
compared to semi-structured interviews, fully structured
interviews, designed for administration by lay interviewers,
identified more participants with low-level depressive symp-
toms but fewer participants with high-level symptoms as
depressed.18-20 One brief fully structured interview, the Mini
International Neuropsychiatric Interview, identified far more
participants as being depressed across the symptom spec-
trum.18-20 Additionally, we excluded data sets that provided
only total EPDS scores without item scores. This is because
item scores were needed to calculate EPDS-5 scores.
Data Sources, Search Strategy, and Study Selection
We searched Medline, Medline In-Process & Other Non-
Indexed Citations and PsycINFO via OvidSP, and the Web
of Science Core Collection via ISI Web of Knowledge from
inception to June 10, 2016. The search was designed by an
experienced medical librarian and peer-reviewed (Appen-
dix).21 We reviewed reference lists from published reviews
and queried collaborators to attempt to identify nonpublished
studies. Search results were uploaded into RefWorks
(RefWorks-COS, Bethesda, MD, USA) and, after duplicate
removal, into DistillerSR (Evidence Partners, Ottawa,
Canada) for managing the review process and data extraction.
Two investigators independently reviewed titles and
abstracts, and if either deemed a study potentially eligible,
full-text review was done by two investigators, indepen-
dently. Any disagreements were resolved by consensus, with
a third investigator consulted if necessary.
Data Contribution and Synthesis
Authors of studies with eligible data sets were contacted and
invited to contribute de-identified primary data sets. We
emailed corresponding authors of eligible primary studies
at least 3 times, with at least 2 weeks between each email.
If there was not a response, we attempted phone contact and
emailed coauthors.
For each contributed data set, we attempted to verify that
we could replicate published participant characteristics and
screening accuracy results, and we resolved any discrepan-
cies, consulting with the study investigators. The number of
participants and cases from a primary study in the IPDMA
data set sometimes differed from numbers in published pri-
mary study reports for several reasons. First, for some primary
studies, not all participants met inclusion criteria for our
IPDMA. This occurred, for instance, if the period between
administration of the EPDS and diagnostic interview was
longer than 2 weeks for some participants. Second, some
primary studies reported accuracy results for depression diag-
noses broader than major depression, such as “any depressive
disorder”, but our reference standard was major depression,
which would have resulted in a different number of cases than
published. Third, in some cases, when we compared pub-
lished results with results from contributed data sets, there
were discrepancies, and we used the corrected results.
For primary data sets that used sampling procedures that
required weighting, we used the weights provided. This
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occurred, for instance, in studies where all participants with
positive screens and a random subset of participants with
negative screens received a diagnostic interview. For studies
where sampling should have been done, but weights were
not available, we used inverse selection probabilities.
Statistical Analyses
For each primary study, we calculated the prevalence of
major depression based on the SCID, the percentage who
scored 7 on the EPDS-5, the difference in prevalence
between the 2 methods (EPDS-5  7 prevalence  SCID
major depression prevalence), and the corresponding ratio.
Then, across studies, we pooled (1) percentage with EPDS-5
7, (2) prevalence of SCID major depression, and (3) the
differences in prevalence from each study. We also deter-
mined the mean and median ratio for EPDS-5 7 versus
SCID major depression prevalence.
All meta-analyses were conducted in R (R version 3.4.1;
R Studio version 1.0.143) using the lme4 package. Given the
clustered nature of the data, mixed-effects models were used.
To estimate pooled prevalence values, generalized linear
mixed-effects models with a logit link function were fit
using the glmer function. The logit link accounts for the
binary nature of the outcome (EPDS-5 7 vs <7; presence
vs. absence of SCID major depression). To estimate the
pooled difference value (fit continuously, given that differ-
ences could be positive or negative), a linear mixed-effects
model was fit using the lmer function. In all analyses, to
account for correlation between subjects within the same
primary study (i.e., the clustering), random intercepts were
fit for each primary study. To quantify heterogeneity, for
each analysis, we (1) calculated t2, which is the estimate
of between-study variance; (2) calculated the I2 statistic,
which quantifies the proportion of total variability due to
between-study heterogeneity; and (3) estimated the 95% pre-
diction interval for the difference in prevalence, which illus-
trates the range of difference values that would be expected
if a new study were to compare proportion with EPDS-5 7
to prevalence based on SCID.
In post hoc analyses, we investigated whether differences
in prevalence (EPDS-5 7 prevalence  SCID major
depression prevalence) were associated with study and par-
ticipant characteristics. To do this, we fit additional linear
mixed-effects models for pooled prevalence difference,
including age, pregnant versus postpartum status, country
human development index (“very high,” “high,” or “low-
medium,” based on the United Nation’s Human Develop-
ment Index for the year of publication), and study sample
size as fixed-effect covariates.
Ethical Approval
Since this study involved analysis of previously collected de-
identified data and because included studies were required to
have obtained ethics approval and informed consent, the
Research Ethics Committee of the Jewish General Hospital
determined that ethics approval was not required.
Results
Search Results and Inclusion of Primary Study Data
Sets
There were 3,417 unique citations identified, of which 3,097
were excluded after review of titles and abstracts and 212
after full-text review. The 108 remaining articles comprised
data from 73 unique samples, of which 49 provided data for
the main IPDMA; in addition, we were provided data from
one unpublished study, which was subsequently published.
For this study, of the 50 study data sets in the main IPDMA,
21 were excluded because they used a diagnostic interview
other than the SCID (19 fully structured interviews, 2 other
semi-structured interviews), and 10 were excluded because
item-level data to calculate EPDS-5 scores were not avail-
able. Thus, data sets from 19 studies were included with
3,958 participants (572 cases of major depression; preva-
lence 14%). Figure 1 shows the search and dataset inclusion
processes, and Table 1 shows the characteristics of each
included study.22-40
Depression Prevalence Based on the SCID versus
EPDS-5 7
The pooled prevalence of SCID major depression was 9.2%
(95% confidence interval [CI], 6.0% to 13.7%; t2¼ 0.901; I2
¼ 94.4%). The pooled percentage of participants who scored
7 on the EPDS-5 was 16.2% (95% CI, 10.7% to 23.8%; t2
¼ 1.044; I2 ¼ 94.6%). The pooled difference from each
study was 8.0% (95% CI ¼ 2.9% to 13.2%; t2 ¼ 0.010; I2
¼ 93.7%; 95% prediction interval ¼ 13.8% to 29.9%). In
the 19 included primary studies, the mean and median ratios
of proportion of EPDS-5 7 versus SCID prevalence were
2.1 and 1.4, respectively (see Table 1).
In post hoc analyses, no study or participant characteris-
tics were significantly associated with differences in preva-
lence, with the exception of age, for which a 1-year increase
in age was associated with a 0.4% (95% CI, 0.2% to 0.7%)
decrease in “EPDS-5 4  SCID” prevalence.
Discussion
The Maternal Mental Health in Canada, 2018/2019, survey
was conducted by Statistics Canada in collaboration with the
Public Health Agency of Canada and Health Canada in order
to address a pressing need for data on maternal mental health
problems, including depression.7 One previous study had
suggested that the EPDS-5 with a cutoff of >7 could be used
as a screening tool for depression, but it was based on only 9
cases and did not attempt to calibrate the tool to estimate
prevalence. Results from the present analysis suggest that
using a score of 7 on the EPDS-5 overestimates true pre-
valence by an absolute value of about 8% or approximately
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1.4 to 2.0 times, depending on whether a mean or median
ratio of EPDS-5 to SCID prevalence is used.
Despite the heterogeneity across studies in our IPDMA, it
is safe to conclude that depression prevalence would be sub-
stantially overestimated by an EPDS-5 cutoff of >7 although
it is less easy to determine the amount of overestimation in
any given study. This finding is similar to other studies that
have found that estimates of prevalence derived from cutoff
scores on screening scales used clinically to detect patients
with possible depression vastly overestimate prevalence by
diagnostic interview.10,11
The implication of using terminology such as “feelings
consistent with postpartum depression,” as used in Maternal
Mental Health in Canada, 2018/2019, survey is also impor-
tant. Diagnostic or classification thresholds are set to iden-










• No original data (3)
• No EPDS (4)
• No major depression (38)
• No validated interview to assess major depression (45)
• > 2 weeks between EPDS and diagnostic interview (20)
• Sample selected for known distress, mental health
diagnosis, or psychiatric setting (72)
• No pregnant or postpartum women (8)
• No adults (6)








1 Study the search did not retrieve, and was provided by
authors of other published eligible studies
50 EPDS studies with
primary data
24 Eligible studies did not provide primary data




• Did not classify major depression
with the SCID (21)
• Did not provide item level data (10)
19 Studies included in the
present study
Figure 1. Flow diagram of the study selection process.
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warrants medical attention. Although women who score 7
on the EPDS-5 have symptoms that are on average more
consistent with depression than those below that threshold,
this does not necessarily mean that they have a diagnosis of
depression or require treatment, making it very difficult to
use the information generated, other than perhaps to com-
pare symptom burden across other populations or samples
using similar thresholds on the same scale.
The overestimation of prevalence may also have implica-
tions beyond assessing depression prevalence itself. For
example, the Maternal Mental Health in Canada survey
reported that 12% of women who were classified as
depressed with EPDS >7 had experienced thoughts of harm-
ing themselves “sometimes” or “often” since the birth of
their child. Since many more women were classified as
depressed than would have met diagnostic criteria based
on a validated interview, it is possible that the true propor-
tion of women with major depression with thoughts of self-
harm could be substantially greater than what was estimated.
Misclassification not only affects our understanding of the
frequency of a condition but also how we understand the
experiences and challenges of those with the condition.
There are many examples of national surveys that have
used validated diagnostic interviews to estimate depression
prevalence. In Canada, the Canadian Community Health
Survey–Mental Health used a version of the World Health
Organization’s fully structured Composite International
Diagnostic Interview (CIDI) to evaluate the prevalence of
MDD with a sample of over 25,000 participants.41 In the
United States, the Epidemiologic Catchment Area Study
used another fully structured interview, the Diagnostic Inter-
view Schedule (DIS),42 and the National Comorbidity Sur-
vey used the CIDI.43 Large cross-national studies have
similarly used the DIS44 and the CIDI.45 The use of validated
diagnostic interviews requires substantial resources. Using
alternative methods, such as the EPDS-5, which overidentify
depression cases, however, makes it difficult to understand
where needs are greatest, identify factors associated with
onset of mental health problems, and find effective solutions.
When resources are not available to properly identify cases,
alternative research questions can be considered.
Strengths and Limitations
An important strength of this study is that it included data
from 19 primary studies with almost 4,000 participants and
almost 600 cases of major depression based on the SCID, a
rigorous semi-structured diagnostic interview designed to
classify psychiatric disorders, including major depression.
We were able to directly compare the proportion of women
with EPDS-5 7 and prevalence of major depression based
on the SCID. A limitation was that included studies came
from many different countries and reported different preva-
lence of major depression although the pooled percentage of
participants with EPDS-5 7 (16%) was similar to that of
the Maternal Mental Health in Canada, 2018/2019, survey















Barnes, 200922 UK 347 71 (20.5) 25 (7.2) 13.3 2.8
Beck, 200123 USA 150 20 (13.3) 18 (12.0) 1.3 1.1
de Figueiredo, 201524a Brazil 242 94 (27.5) 95 (29.6) 2.1 0.9
Helle, 201525 Germany 225 42 (18.7) 12 (5.3) 13.3 3.5
Howard, 201826a UK 532 173 (17.0) 130 (9.4) 7.6 1.8
Leonardou, 200927 Greece 81 13 (16.0) 4 (4.9) 11.1 3.3
Nakić Radoš, 201328 Croatia 272 32 (11.8) 10 (3.7) 8.1 3.2
Phillips, 200929 Australia 158 70 (44.3) 42 (26.6) 17.7 1.7
Prenoveau, 201330a UK 220 51 (14.7) 20 (6.0) 8.7 2.5
Quispel, 201531 The Netherlands 31 0 (0.0) 0 (0.0) 0.0 —
Rochat, 201332 South Africa 104 66 (63.5) 50 (48.1) 15.4 1.3
Stewart, 201333a Malawi 186 46 (11.2) 34 (10.1) 1.1 1.1
Tandon, 201234 USA 89 34 (38.2) 25 (28.1) 10.1 1.4
Tendais, 201435a Portugal 141 29 (10.9) 18 (7.6) 3.3 1.4
Töreki, 201336 Hungary 219 6 (2.7) 7 (3.2) 0.5 0.9
Töreki, 201437 Hungary 265 20 (7.5) 8 (3.0) 4.5 2.5
Tran, 201138 Vietnam 361 28 (7.8) 53 (14.7) 6.9 0.5
Turner, 200939 Italy 29 2 (6.9) 2 (6.9) 0.0 1.0
Vega-Dienstmaier, 200240 Peru 306 148 (48.4) 19 (6.2) 42.2 7.8










Note: EPDS¼ Edinburgh Postnatal Depression Scale; SCID¼ Structured Clinical Interview for DSM; UK¼United Kingdom; USA¼United States of America.
aSampling weights were applied. Counts are based on actual numbers whereas percentages are weighted.
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(18%). Another was that the search included studies only
through June 2016. There was also considerable heterogene-
ity across studies in the difference between prevalence esti-
mated with EPDS-5 7 versus the SCID. Although age was
statistically significantly associated with the difference
between EPDS-57 prevalence and SCID major depression
prevalence, a 1-year difference was associated with only a
0.4% difference; given the general similarity in ages of preg-
nant and postpartum women, this would not explain the large
differences we found. Despite these limitations, there was
robust evidence that the EPDS-57 generally overestimates
depression prevalence and that the magnitude of the over-
estimation appears to be clinically important.
Conclusions
In summary, we found that using EPDS-5 7 to estimate
depression overestimates the true prevalence of depression
substantially. As such, while the 18% reported in the Mater-
nal Mental Health in Canada, 2018/2019, survey reflects a
certain burden of depressive symptomatology, policymakers
may not be able to use it as a benchmark for planning levels
of specific services because many of those scoring 7 or
above on a scale such as the EPDS-5 would not be diagnosed
with MDD in a clinical interview. Postpartum depression is
an important and burdensome condition, and as such, future
surveys should use validated diagnostic interviews designed
for diagnostic calibration to understand prevalence and pro-
vide more accurate data to use as a benchmark for policy-
makers to be able to act on need for service to improve
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